It’s that it (currently) doesn't scale well, not like a SaaS company can, anyway. Treatment is a bit more involved than here's some shrooms in the mail, so there's profit to be made, and quite a lot of it, just not how VC investor have been operating. They won't get out of bed for a million dollar idea. Maybe for 10.